We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+10.19%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$125B
AUM Growth
+$7.74B
Cap. Flow
-$1.18B
Cap. Flow %
-0.95%
Top 10 Hldgs %
32.47%
Holding
4,267
New
79
Increased
1,134
Reduced
2,614
Closed
100

Top Buys

Rank Stock Value
1
APP icon
Applovin
APP
+$80.1M
2
CVX icon
Chevron
CVX
+$75.4M
3
HOOD icon
Robinhood
HOOD
+$52.2M
4
NTNX icon
Nutanix
NTNX
+$32.2M
5
DDOG icon
Datadog
DDOG
+$29.9M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$166M
2
AAPL icon
Apple
AAPL
+$150M
3
NVDA icon
NVIDIA
NVDA
+$148M
4
HES
Hess
HES
+$72.3M
5
ANSS
Ansys
ANSS
+$59M

Sector Composition

Rank Sector Weight
1 Technology 32.89%
2 Financials 13.4%
3 Consumer Discretionary 10.96%
4 Communication Services 9.45%
5 Healthcare 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRM
3501
MEDIROM Healthcare Technologies
MRM
$7.59M
$2.77K ﹤0.01%
1,307
+207
+19% +$347
GDS icon
3502
GDS Holdings
GDS
$6.41B
$2.71K ﹤0.01%
70
-80
-53% -$2.84K
VALN
3503
Valneva
VALN
$541M
$2.66K ﹤0.01%
218
+167
+327% +$1.43K
CUK
3504
DELISTED
Carnival PLC
CUK
$2.64K ﹤0.01%
100
SII
3505
Sprott
SII
$3.03B
$2.58K ﹤0.01%
31
STHO icon
3506
Star Holdings Shares of Beneficial Interest
STHO
$116M
$2.58K ﹤0.01%
313
DDI
3507
DoubleDown Interactive
DDI
$588M
$2.52K ﹤0.01%
270
ATRA icon
3508
Atara Biotherapeutics
ATRA
$76.1M
$2.51K ﹤0.01%
175
XBIT icon
3509
XBiotech
XBIT
$69.2M
$2.47K ﹤0.01%
928
BMEA icon
3510
Biomea Fusion
BMEA
$91.3M
$2.42K ﹤0.01%
1,200
PSNY icon
3511
Polestar Automotive Holding UK
PSNY
$2.06B
$2.33K ﹤0.01%
83
+10
+14% +$320
NCNA
3512
NuCana
NCNA
$6.12M
$2.29K ﹤0.01%
495
+455
+1,138% +$2.91K
TUYA
3513
Tuya Inc
TUYA
$1.1B
$2.26K ﹤0.01%
915
AMBR
3514
Amber International Holding Ltd
AMBR
$130M
$2.22K ﹤0.01%
663
-1,079
-62% -$6.42K
VRA icon
3515
Vera Bradley
VRA
$98.7M
$2.21K ﹤0.01%
1,100
ZKH
3516
ZKH Group
ZKH
$454M
$2.21K ﹤0.01%
+775
New +$2.31K
NGD
3517
DELISTED
New Gold Inc
NGD
$2.15K ﹤0.01%
300
TMC icon
3518
TMC The Metals Company
TMC
$1.98B
$2.12K ﹤0.01%
333
HIVE
3519
HIVE Digital Technologies
HIVE
$777M
$2.08K ﹤0.01%
515
CAE icon
3520
CAE Inc. Common Shares
CAE
$8.74B
$2.07K ﹤0.01%
70
AGEN
3521
Agenus
AGEN
$290M
$2.07K ﹤0.01%
538
SQNS
3522
Sequans Communications SA
SQNS
$41.3M
$2.05K ﹤0.01%
217
-47
-18% -$720
CAN
3523
Canaan Creative
CAN
$159M
$2.04K ﹤0.01%
2,320
TIL icon
3524
Instil Bio
TIL
$50.3M
$2.04K ﹤0.01%
114
GENE
3525
DELISTED
Genetic Technologies Ltd.
GENE
$2.03K ﹤0.01%
2,650
-690
-21% -$528

Similar funds

RhumbLine Advisers's Q3 2025 Portfolio in Review

As of Q3 2025, RhumbLine Advisers held 4,267 positions worth $125B, up 6.6% from $117B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Trading was light in Q3 2025: portfolio turnover was 4.2%. RhumbLine Advisers opened 79 new positions and exited 100, leaving the 4,267-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Discretionary.

  • RhumbLine Advisers's largest Q3 2025 buy was The Marzetti Company: 64,390 shares worth $11.1M.
  • RhumbLine Advisers added most to Applovin in Q3 2025, an estimated $80.1M increase.
  • RhumbLine Advisers's biggest Q3 2025 reduction was Microsoft, cutting an estimated $166M.
  • RhumbLine Advisers fully exited Hess in Q3 2025, selling an estimated $72.3M.
  • RhumbLine Advisers's ten largest holdings make up 32% of its $125B portfolio in Q3 2025.
  • RhumbLine Advisers opened 79 new positions and closed 100 in Q3 2025.
  • RhumbLine Advisers's portfolio value rose 6.6% quarter-over-quarter to $125B.

Based on RhumbLine Advisers's 13F filing for Q3 2025, filed 6 Nov 2025.